j-chan documents

Selected Works
Documents Selected Works
Usefulness of thyrogastric immune features as predictors of pernicious anaemia that lacks intrinsic factor antibody
Documents Usefulness of thyrogastric immune features as predictors of pernicious anaemia that lacks intrinsic factor antibody
Enhancing sport leadership through development of emotional intelligence competencies
Documents Enhancing sport leadership through development of emotional intelligence competencies
The prognostic significance of pre-operative vs. prechemotherapy CA-125 in high-risk early-stage epithelial ovarian cancer: A gynecologic oncology group study
Documents The prognostic significance of pre-operative vs. prechemotherapy CA-125 in high-risk early-stage epithelial ovarian cancer: A gynecologic oncology group study
MicroRNA as a novel predictor of response to bevacizumab in recurrent serous ovarian cancer: An analysis of The Cancer Genome Atlas
Documents MicroRNA as a novel predictor of response to bevacizumab in recurrent serous ovarian cancer: An analysis of The Cancer Genome Atlas
An economic analysis of bevacizumab in recurrent treatment of ovarian cancer
Documents An economic analysis of bevacizumab in recurrent treatment of ovarian cancer
The association of VEGF A, B, and C expression in the survival of serous ovarian cancer patients
Documents The association of VEGF A, B, and C expression in the survival of serous ovarian cancer patients
A practical prediction model for determining bevacizumab response and toxicity in the treatment of advanced ovarian and peritoneal cancers – An analysis of GOG 218
Documents A practical prediction model for determining bevacizumab response and toxicity in the treatment of advanced ovarian and peritoneal cancers – An analysis of GOG 218
Factors predictive of toxicity associated with bevacizumab and chemotherapy in recurrent ovarian cancer: A multi-institutional study
Documents Factors predictive of toxicity associated with bevacizumab and chemotherapy in recurrent ovarian cancer: A multi-institutional study
Chemotherapy response and survival in serous ovarian cancer patients with BRCA mutations
Documents Chemotherapy response and survival in serous ovarian cancer patients with BRCA mutations
Outcomes of ovarian cancer patients after bevacizumab and chemotherapy in primary vs. recurrent setting – A multi-institutional study
Documents Outcomes of ovarian cancer patients after bevacizumab and chemotherapy in primary vs. recurrent setting – A multi-institutional study
A cost effective strategy of bevacizumab in treatment of primary ovarian cancer — A subset analysis of ICON 7 trial
Documents A cost effective strategy of bevacizumab in treatment of primary ovarian cancer — A subset analysis of ICON 7 trial
The pattern of CA-125 normalization during chemotherapy predicts for recurrence and survival in patients with high-risk early-stage ovarian cancer: A gynecologic oncology group study
Documents The pattern of CA-125 normalization during chemotherapy predicts for recurrence and survival in patients with high-risk early-stage ovarian cancer: A gynecologic oncology group study
Microtubule and cellulose microfibril orientation during plant cell and organ growth
Documents Microtubule and cellulose microfibril orientation during plant cell and organ growth
24. Factors Predictive of 30-Day Post-Operative Mortality in HIV/AIDS Patients Being Treated With Anti-Retroviral Therapy
Documents 24. Factors Predictive of 30-Day Post-Operative Mortality in HIV/AIDS Patients Being Treated With Anti-Retroviral Therapy
Maternal antibodies to rotavirus: Could they interfere with live rotavirus vaccines in developing countries?
Documents Maternal antibodies to rotavirus: Could they interfere with live rotavirus vaccines in developing countries?
Extraction of correct Schottky barrier height of sulfur implanted NiSi/n-Si junctions: Junction doping rather than barrier height lowering
Documents Extraction of correct Schottky barrier height of sulfur implanted NiSi/n-Si junctions: Junction doping rather than barrier height lowering